The Nifty 50 declined by 2% CAGR between October 1, 2010, and September 30, 2013. In US dollar terms, Nifty 50 underperformed other markets too. The benchmark index declined by 34% in dollar terms, S&P 500 was up 47%, and the MSCI World index was up 30% during this period.
Moderna shares soar 135% in a day after cancer vaccine succeeds in late-stage trial
Moderna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, reduced melanoma recurrence and spread significantly. This